Anakinra, a recombinant human IL-1 receptor antagonist, in clinical practice. Outcome in 60 patients with severe rheumatoid arthritis. Reumatismo [Internet]. 2007 Mar. 30 [cited 2025 Jun. 7];59(1):32-7. Available from: https://www.reumatismo.org/reuma/article/view/reumatismo.2007.32